Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis
Open Access
- 11 August 2017
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (8) , 1756
Abstract
The literature on Galectin-3 (Gal-3) was systematically reviewed to achieve more robust information on its histologic reliability in identifying thyroid cancers and on the concordance between Gal-3 test in histologic and cytologic samples. A computer search of the PubMed and Scopus databases was conducted by combinations of the terms thyroid and Gal-3. Initially, 545 articles were found and, after their critical review, 52 original papers were finally included. They reported 8172 nodules with histologic evaluation of Gal-3, of which 358 with also preoperative FNAC Gal-3 assessment. At histology, Gal-3 sensitivity was 87% (95% confidence intervals [CI] from 86% to 88%), and specificity 87% (95% CI from 86% to 88%); in both cases, we found heterogeneity (I2 85% and 93%, respectively) and significant publication bias (p < 0.001). The pooled rate of positive Gal-3 at fine needle aspiration (FNAC) among cancers with histologically proven Gal-3 positivity was 94% (95% CI from 89% to 97%), with neither heterogeneity (I2 14.5%) nor bias (p = 0.086). These data show high reliability of Gal-3 for thyroid cancer at histology, while its sensitivity on FNAC samples is lower. The limits of cytologic preparations and interpretation of Gal-3 results have to be solved.Keywords
This publication has 84 references indexed in Scilit:
- Serum biomarkers of papillary thyroid cancerJournal of Otolaryngology - Head & Neck Surgery, 2013
- Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of ChinaDiagnostic Pathology, 2011
- Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinomaJournal of Clinical Pathology, 2010
- Diagnostic Utility of Galectin-3 in Thyroid CancerThe American Journal of Pathology, 2010
- Dynamics of galectin-3 in the nucleus and cytoplasmBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodulesDiagnostic Pathology, 2010
- Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3PLOS ONE, 2008
- Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignanciesBiochemical and Biophysical Research Communications, 2008
- Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytologyBritish Journal of Cancer, 2006
- Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancyHistopathology, 2005